VAMP1

vesicle associated membrane protein 1, the group of Vesicle associated membrane proteins

Basic information

Region (hg38): 12:6462237-6470677

Previous symbols: [ "SYB1" ]

Links

ENSG00000139190NCBI:6843OMIM:185880HGNC:12642Uniprot:P23763AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myasthenic syndrome, congenital, 25, presynaptic (Strong), mode of inheritance: AR
  • myasthenic syndrome, congenital, 25, presynaptic (Strong), mode of inheritance: AR
  • presynaptic congenital myasthenic syndrome (Supportive), mode of inheritance: AD
  • spastic ataxia 1 (Supportive), mode of inheritance: AD
  • myasthenic syndrome, congenital, 25, presynaptic (Strong), mode of inheritance: AR
  • spastic ataxia 1 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myasthenic syndrome, congenital, 25, presynapticARMusculoskeletal; NeurologicThe condition can involve neonatal hypotonia and generalized muscle weakness, and medicial management (with pyridostigmine) has been described as beneficialMusculoskeletal; Neurologic11774073; 22958904; 28168212; 28253535; 28600779

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the VAMP1 gene.

  • Spastic_paraplegia (88 variants)
  • not_provided (22 variants)
  • Myasthenic_syndrome,_congenital,_25,_presynaptic (9 variants)
  • Inborn_genetic_diseases (5 variants)
  • Spastic_ataxia_1 (4 variants)
  • VAMP1-related_disorder (2 variants)
  • Houge-Janssens_syndrome_2 (1 variants)
  • Congenital_myasthenic_syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the VAMP1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014231.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
14
clinvar
15
missense
34
clinvar
34
nonsense
3
clinvar
3
start loss
0
frameshift
3
clinvar
4
clinvar
2
clinvar
9
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
3
clinvar
6
Total 5 8 40 14 0

Highest pathogenic variant AF is 0.000015489852

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
VAMP1protein_codingprotein_codingENST00000396308 58751
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.003940.8671257370111257480.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.233866.30.5730.00000332764
Missense in Polyphen1016.8690.5928222
Synonymous0.4712022.90.8750.00000112233
Loss of Function1.2859.180.5455.76e-787

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005780.0000578
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00004400.0000439
Middle Eastern0.0001090.000109
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the targeting and/or fusion of transport vesicles to their target membrane.;
Disease
DISEASE: Spastic ataxia 1, autosomal dominant (SPAX1) [MIM:108600]: An autosomal dominant form of spastic ataxia, a progressive neurodegenerative disorder characterized by lower-limb spasticity and generalized ataxia with dysarthria, impaired ocular movements, and gait disturbance. {ECO:0000269|PubMed:22958904}. Note=The disease is caused by mutations affecting the gene represented in this entry. A mutation affecting a critical donor site for the splicing of VAMP1 isoforms leads to the loss of neuron-specific isoform 1 and subsequently results in haploinsufficiency (PubMed:22958904). Therefore, there would be less neurotransmitter exocytosis in specific regions of the brain, causing the symptoms of SPAX1. {ECO:0000303|PubMed:22958904}.;
Pathway
SNARE interactions in vesicular transport - Homo sapiens (human);Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics;Disease;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type F (BoNT/F);Uptake and actions of bacterial toxins;Toxicity of botulinum toxin type G (BoNT/G);Neurotoxicity of clostridium toxins;Infectious disease (Consensus)

Recessive Scores

pRec
0.137

Intolerance Scores

loftool
rvis_EVS
0.24
rvis_percentile_EVS
68.72

Haploinsufficiency Scores

pHI
0.174
hipred
Y
hipred_score
0.514
ghis
0.552

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.815

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Vamp1
Phenotype
growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
synaptic vesicle priming;regulation of synaptic vesicle fusion to presynaptic active zone membrane;SNARE complex assembly
Cellular component
mitochondrial outer membrane;cytosol;integral component of plasma membrane;cell surface;cell junction;integral component of synaptic vesicle membrane;synaptic vesicle membrane;neuromuscular junction;azurophil granule membrane;specific granule membrane;neuron projection;tertiary granule membrane;glutamatergic synapse
Molecular function
protein binding